In this study, we used oral melatonin to treat APP/PS1 transgenic mice and confirmed the protective role of melatonin in AD by water maze tests and assessment of Aβ deposition and soluble Aβ40 and Aβ42 concentrations. Here, APP is linked to Alzheimer disease.